Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05319847 · ClinicalTrials.gov registry record · NA
An Exploratory Investigation of a Male Focused Skincare Supplement
A NA study of Acne and Skin Abnormalities, sponsored by Let's Dis.
- Completed
- Registry status
- NA
- Development phase
- 38
- Enrollment target
- 1
- Study location
NCT05319847: Completed NA study of Acne and Skin Abnormalities, sponsored by Let's Dis.
NCT05319847 is a NA study of Acne and Skin Abnormalities that has completed, run by Let's Dis. The registered enrollment target is 38 participants, below the 141-participant average among 26 other Acne trials with a reported enrollment target (73% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05319847, a NA study of Acne and Skin Abnormalities, has completed, sponsored by Let's Dis.
- COMPLETED
- Registry status
- NA
- Development phase
- 38 participants
- Enrollment target
- 1
- Study location
Study Summary
Most skincare products on the market are topical and do not take a holistic approach to understanding skin health. This trial will examine a dietary supplement designed to support the gut microbiome and promote skin health from an internal perspective. Research has previously supported the link between the gut microbiome and skin health and the supplement tested in this trial will further the knowledge on the effectiveness of supporting gut health to improve skin outcomes.
Primary Outcome
Change in overall frequency and intensity of adult acne (Likert Scale 0-5 with higher scores representing a reduction in the appearance of adult acne)
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Daily Skin Supplement - Fountain of Youth
Study Locations (1)
California
- Citruslabs - Santa Monica
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 38 participants |
| Start Date | 2022-04-15 |
| Est. Completion | 2022-06-30 |
| Phase | NA |
What the finished NCT05319847 record still lists
NCT05319847 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 38 participants, a relatively small participant target, below the 141-participant average among 26 other Acne trials with a reported enrollment target (73% lower).
The record links to 2 conditions, with Acne appearing as the primary indexed condition, and to 1 intervention - of which Daily Skin Supplement - Fountain of Youth is the first listed.
NCT05319847 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT05319847 about?
NCT05319847 is a clinical study titled "An Exploratory Investigation of a Male Focused Skincare Supplement". Most skincare products on the market are topical and do not take a holistic approach to understanding skin health. This trial will examine a dietary supplement designed to support the gut microbiome and promote skin health from an internal perspective. Research has previously supported the link betw...
What is the current status of trial NCT05319847?
This trial is currently completed. It is a NA study. The enrollment target is 38 participants. The study started on 2022-04-15. Estimated completion is 2022-06-30.
What conditions does trial NCT05319847 study?
This clinical trial studies the following conditions: Acne, Skin Abnormalities.
What interventions are being tested in trial NCT05319847?
The interventions under investigation include: Daily Skin Supplement - Fountain of Youth (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT05319847?
This trial is sponsored by Let's Dis, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05319847 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Acne
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05319847's enrollment target sits among peer trials
38 18th of 26 higher than 8 of 26 other Acne trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Acne trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
AVAVA MIRIA General Use
RECRUITING · NA
-
Single-Blind Study Assessing the Use of a Topical Antioxidant With A Series of Laser Procedures to Reduce Sebum Production
RECRUITING · NA
-
The Use of Image-Based Computer Gradings in the Analysis of Acne, Rosacea, Melasma, and Seborrheic Dermatitis
RECRUITING · NA
-
Clinical Study to Evaluate the Safety and Efficacy of Candela Technology
ACTIVE NOT RECRUITING · NA
-
The Effects of Cetyl Tranexamate Mesylate on the Appearance of Acne-Related Hyperpigmentation
COMPLETED · NA
-
An Exploratory Investigation of a Novel Skincare Regimen
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01684904 · 38 participants · NA
Proton Therapy for Esophageal Cancer
- NCT03310879 · 38 participants · Phase 2
Study of the CDK4/6 Inhibitor Abemaciclib in Solid Tumors Harboring Genetic Alterations in Genes Encoding D-Type Cyclins or Amplification of CDK4 or CDK6
- NCT03896269 · 38 participants · Phase 1
CPX-351 in Treating Patients With Relapsed or Refractory High Risk Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia
- NCT04085315 · 38 participants · Phase 1
Alisertib in Combination With Osimertinib in Metastatic EGFR-mutant Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI